Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 710 (USA) (Dr. Silva)
· consented 2012-11-30
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate COMPLEX PARTIAL SEIZURES — outcome: RECOVERED/RESOLVED; onset 2013-03-19 (study day 110.0); relationship: POSSIBLE; serious criteria: hospitalization
moderate
assessed
2026-08-18
Moderate FALL — outcome: RECOVERED/RESOLVED; onset 2013-03-19 (study day 110.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate SKIN LACERATION — outcome: RECOVERED/RESOLVED; onset 2013-03-19 (study day 110.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-03-19 (study day 110.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-03-20 (study day 111.0); relationship: POSSIBLE; serious criteria: hospitalization
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.